Literature DB >> 3106301

Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method.

H B Drugeon, J Caillon, M E Juvin, J L Pirault.   

Abstract

Since in-vitro methods for studying drug interactions are difficult to evaluate and different results occur with the chequerboard (isobolograms-FIC index) and killing curve methods, a new approach associating these two methods was used to study the ceftazidime-pefloxacin interaction. In 64 tubes in a chequerboard pattern, viable bacteria were counted at 0, 2.5, 5 and 24 h, by a microdilution method and a multiple inoculator replicating method. The bacterial inoculum consisted of 5 X 10(6)-10(7) cfu/ml. Twelve strains belonging to six genera were tested: Acinetobacter, Citrobacter, Enterobacter, Klebsiella, Serratia and Pseudomonas. During the first 5 h no antagonism was noted, but few differences in viable count equal to or greater than 2 log10 were observed. The results of the drug interaction were equivalent to those of the more rapid bactericidal antibiotic concentrations (ceftazidime or pefloxacin). At 24 h, synergy was observed: ceftazidime prevented the late regrowth noted with pefloxacin, but with Citrobacter spp. regrowth was also observed with ceftazidime and none of the combinations were bactericidal.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106301     DOI: 10.1093/jac/19.2.197

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.

Authors:  Cedric Jacqueline; Jocelyne Caillon; Olivier Grossi; Virginie Le Mabecque; Anne-Françoise Miegeville; Denis Bugnon; Eric Batard; Gilles Potel
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.

Authors:  M E Juvin; G Potel; J Caillon; Y Q Xiong; D Bugnon; P Le Conte; D I Baron; H B Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

3.  Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.

Authors:  G Potel; J Caillon; B Fantin; J Raza; F Le Gallou; J Y Lepage; P Le Conte; D Bugnon; D Baron; H Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

4.  Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients.

Authors:  L Marty; A Flahault; B Suarez; J Caillon; C Hill; A Andremont
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

5.  Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.

Authors:  Y Q Xiong; G Potel; J Caillon; G Stephant; F Jehl; D Bugnon; P Le Conte; D Baron; H Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

6.  Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.

Authors:  G Potel; J Caillon; F Le Gallou; D Bugnon; P Le Conte; J Raza; J Y Lepage; D Baron; H Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.